🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The principal aim of this study was to asses the effects of motor imagery a...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-05
Trial ID
NCT05662072
Treatments Being Tested
This study evaluates the influence of motor imagery or action observation t...
Status
Unknown
Location
CSEU La Salle
Start Date
2019-04-15
Trial ID
NCT03910829
Treatments Being Tested
The purpose of this study is to determine whether Asacol® 2.4 g/day (400 mg...
Status
Completed
Location
Research Site
Start Date
2007-11
Trial ID
NCT00554099
Treatments Being Tested
This study evaluates the influence of motor imagery and action observation ...
Status
Unknown
Location
CSEU La Salle
Start Date
2020-01-01
Trial ID
NCT04191083
Treatments Being Tested
Allergic rhinitis (AR) is a common condition, with nearly 300 million affec...
Status
Unknown
Location
Chongqing Medical University
Start Date
2023-08-01
Trial ID
NCT06272032
The main objective of this research is to evaluate and quantify successes a...
Status
Unknown
Location
CSEU La Salle
Start Date
2018-12-06
Trial ID
NCT03769974
Treatments Being Tested
This study aims to assess the immediate effects of action observation thera...
Status
Completed
Location
School of Health Sciences, University of Aveiro
Start Date
2021-11-20
Trial ID
NCT05078489
Treatments Being Tested
The main objective is to evaluate the effects of action-observation trainin...
Status
Unknown
Location
CSEU La Salle
Start Date
2020-11-15
Trial ID
NCT04615598
Treatments Being Tested
The goal of this study is to see if a short educational session and demonst...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01
Trial ID
NCT07364643
Treatments Being Tested
This is a prospective, randomized, multicenter, double-blind, placebo-contr...
Status
Completed
Location
Shenzhen Kangning Hospital
Start Date
2023-04-21
Trial ID
NCT05554289